Patent pools and standard setting in diagnostic genetics

Nature Biotechnology

Volumn 23, Issue 8, 2005, Pages 937-938

  Ebersole, Ted J ^a   Guthrie, Marvin C ^a   Goldstein, Jorge A ^a  

^a Off of Sterne Kessler Goldstein/Fox   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST CONTROL; COURT; GENE MUTATION; GENE POOL; GENETIC ANALYSIS; GENETIC DISORDER; GENOMICS; HEALTH CARE ACCESS; HUMAN; LICENSING; MARKET; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; PATENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT SURVEY; STANDARD; STANDARDIZATION; UNITED STATES;

BIOTECHNOLOGY; GENETIC SCREENING; INTERNATIONAL COOPERATION; OWNERSHIP; PATENTS;

EID: 23444446348     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0805-937     Document Type: Short Survey

References (8)

1. Merz, J.F. Clin. Chem. 45, 324-330 (1999).
2. Barton, J.H. Acad. Med. 77, 1339-1347 (2002).
3. Eisenberg, R.S. Acad. Med. 77, 1381-1387 (2002).
4. Andrews, L.B. Nat Rev. Genet. 3, 803-808 (2002).
5. th Congress, Gene Patenting. H.R. 3966 and H.R. 3967.
6. Antitrust Guidelines for the Licensing of Intellectual Property issued by the US Department of Justice and the Federal Trade Commission, § 5.5 (1995).
7. Grody, W.W. et al. Genet. Med. 3, 149-154 (2001).
8. Goldstein, J.A., Ebersole, T.J., Guthrie, M.C., Hirschfeld, A.A. & van den Broek, B.J. Drug Discov. World Spring, 87-91 (2005).